Fortimedix has been acquired by Medtronic

Fortimedix Surgical has been successfully acquired by Medtronic (NYSE: MDT). Following the transaction, Fortimedix will operate as Medtronic Articulating Technologies.

Located at the Brightlands Chemelot Campus in Geleen, the Netherlands, Fortimedix operates a fully equipped R&D and pilot manufacturing facility that allows the seamless integration of product development and pilot manufacturing under a single roof.

Oaklins’ team in the Netherlands acted as the exclusive sell-side M&A advisor to Fortimedix in its sale to Medtronic. This transaction underscores Oaklins’ strong international track record in the medical technology sector, demonstrating their ability to unlock significant value in a rapidly evolving, innovation-driven industry. Leveraging deep sector expertise and a global network of strategic buyers, the team ensured a smooth and successful transaction process for all parties involved.

Servicio

M&A sell-side

Partes

“Our goal was to find a strategic partner for Fortimedix capable of bringing our innovative technologies into full-scale production and into operating rooms worldwide. With Medtronic, we have now found the right partner who can take the next step in delivering groundbreaking instruments to the clinic. The intensive and very pleasant collaboration with Oaklins ultimately led to this transaction. The team’s guidance and results-oriented approach proved invaluable throughout the entire process.”

Wout Bijker

CEO, Fortimedix Surgical

Contáctese con el equipo de la transacción

Robert Boersma

Socio

Amsterdam, Países Bajos
Oaklins Netherlands

Ver perfil Contáctenos

Robbert Bon

Asociado Senior

Amsterdam, Países Bajos
Oaklins Netherlands

Ver perfil Contáctenos

Oscar van Rijn

Asociado

Amsterdam, Países Bajos
Oaklins Netherlands

Ver perfil Contáctenos

Transacciones relacionadas

Rare Patient Voice has been acquired by Konovo

Salud | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Aprenda más

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Salud

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Aprenda más

EuroHospital Varna has been acquired by Intermedica Group

Salud

EuroHospital Varna has been acquired by Intermedica Group

EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.

Aprenda más